首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Jama otolaryngology-head & neck surgery

缩写:JAMA OTOLARYNGOL

ISSN:2168-6181

e-ISSN:2168-619X

IF/分区:5.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3397
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kaitlin Hori,Choo Phei Wee,Nicholas Liu et al. Kaitlin Hori et al.
Importance: Loud music in group fitness classes is often believed to enhance motivation and performance but poses a risk for noise-induced hearing loss. O...
Eddy P Lincango,Luis Vilatuna-Andrango,Andrea Arce-Camposano et al. Eddy P Lincango et al.
Importance: Total thyroidectomy is the established surgical standard for hereditary and sporadic medullary thyroid cancer (sMTC). However, for unilateral sporadic tumors, its benefit over lobectomy remains uncertain. ...
Lacey Nelson,Michael A Belsky,Kara D Meister et al. Lacey Nelson et al.
Importance: Unilateral vocal fold immobility (UVFI) is a common complication of cardiothoracic surgery in pediatric populations, yet no standardized treatment guidelines exist. The current literature supporting pediatric ...
Glenn J Hanna,Olga Y Zamulko,Punita Grover et al. Glenn J Hanna et al.
Importance: Adenoid cystic carcinoma (ACC) is a rare salivary gland tumor treated locally with surgery and radiation therapy. Despite high recurrence and distant failure rates, there is no approved systemic therapy for re...
Carlos Garcia-Lozano,Carlos Betancourt,Juan G Sanchez et al. Carlos Garcia-Lozano et al.
Importance: Postoperative hypocalcemia is the most frequent complication after total thyroidectomy. Prophylactic supplementation with calcium and calcitriol (C+C) is widely used, but selective administration based on earl...
Andrew M Peterson,Dustin Stwalley,Dorina Kallogjeri et al. Andrew M Peterson et al.
Importance: Immunotherapy is approved for first-line treatment of recurrent/metastatic head and neck cancer (HNC). The prescribing patterns are largely unreported, and assessment of immune-related adverse events (irAEs) i...